UB Paderborn / Katalog / Suche / in CDI

Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08

British journal of cancer, 2020-11, Vol.123 (10), p.1490-1495

2020

Link zum Volltext

Verfügbarkeit prüfen

Circulating cell-free DNA methylation patterns as non-invasive biomarkers to monitor colorectal cancer treatment efficacy without referencing primary site mutation profiles

Molecular cancer, 2024-01, Vol.23 (1), p.1-1, Article 1

2024

Link zum Volltext

Verfügbarkeit prüfen

Genomically Stable Gastric Cancer Characterized by Hypomethylation in Wnt Signal Cascade

Oncology, 2023-02, Vol.101 (2), p.105-116

2023

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI)

International journal of clinical oncology, 2021-02, Vol.26 (2), p.399-408

2021

Link zum Volltext

Verfügbarkeit prüfen

The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)

BMC cancer, 2019-10, Vol.19 (1), p.941-6, Article 941

2019

Link zum Volltext

Verfügbarkeit prüfen

Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study)

International journal of clinical oncology, 2019-10, Vol.24 (10), p.1223-1230

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study

International journal of clinical oncology, 2021-07, Vol.26 (7), p.1238-1247

2021

Link zum Volltext

Verfügbarkeit prüfen

Adoptive immunotherapy for gastric cancer using zoledronate‑activated killer cells: A prospective observational study

Molecular and clinical oncology, 2020-11, Vol.13 (5), p.1-1

2020

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Nutritional Index as a Predictor of Postoperative Outcome in Patients Aged 85 Years or Older After Colorectal Cancer Surgery

Indian journal of surgery, 2020-10, Vol.82 (5), p.874-878

2020

Link zum Volltext

Verfügbarkeit prüfen

Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer

Molecular cancer therapeutics, 2018-12, Vol.17 (12), p.2788-2795

2018

Link zum Volltext

Verfügbarkeit prüfen

Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety

International journal of clinical oncology, 2019-07, Vol.24 (7), p.836-841

2019

Link zum Volltext

Verfügbarkeit prüfen

Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer

Future science OA, 2021-12, Vol.7 (10), p.FSO757-FSO757

2021

Link zum Volltext

Verfügbarkeit prüfen

Patient‐reported symptom burden as a prognostic factor in treatment with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial

Cancer medicine (Malden, MA), 2020-03, Vol.9 (5), p.1779-1789

2020

Link zum Volltext

Verfügbarkeit prüfen

S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102)

International journal of clinical oncology, 2016-08, Vol.21 (4), p.705-712

2016

Link zum Volltext

Verfügbarkeit prüfen

CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer

Targeted oncology, 2017-12, Vol.12 (6), p.787-794

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of taurine on acinar cell apoptosis and pancreatic fibrosis in dibutyltin dichloride-induced chronic pancreatitis

Acta medica Okayama, 2012-08, Vol.66 (4), p.329-334

2012

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Phase II Study of Trastuzumab Beyond Progression in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: WJOG7112G (T-ACT Study)

Journal of clinical oncology, 2020-06, Vol.38 (17), p.1919-1927

2020

Link zum Volltext

Verfügbarkeit prüfen

Design of High-Density Cable Parameters for Controlling Spatial-Mode Dispersion of Randomly Coupled Multi-Core Fibers

Journal of lightwave technology, 2021-02, Vol.39 (4), p.1179-1185

2021

Link zum Volltext

Verfügbarkeit prüfen

Oral administration of taurine improves experimental pancreatic fibrosis

Journal of gastroenterology and hepatology, 2008-02, Vol.23 (2), p.321-327

2008

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and outcomes of acute hepatitis B in Okayama, Japan, 2006-2010

Acta medica Okayama, 2014-08, Vol.68 (4), p.243-247

2014

Link zum Volltext

Verfügbarkeit prüfen

Histological study on pN upgrading of oral cancer

Virchows Archiv : an international journal of pathology, 2000-08, Vol.437 (2), p.116-121

2000

Link zum Volltext

Verfügbarkeit prüfen

Neutrophil‑to‑lymphocyte ratio before each chemotherapy line predicts clinical outcomes in patients with unresectable gastric cancer

Oncology letters, 2023-03, Vol.25 (3), p.1, Article 98

2023

Link zum Volltext

Verfügbarkeit prüfen

QoL analysis: A randomized phase 3 study of sequential versus combination treatment in first-line chemotherapy for metastatic colorectal cancer—The C-cubed study

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.102-102

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08

Circulating cell-free DNA methylation patterns as non-invasive biomarkers to monitor colorectal cancer treatment efficacy without referencing primary site mutation profiles

Genomically Stable Gastric Cancer Characterized by Hypomethylation in Wnt Signal Cascade

A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI)

Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial

The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)

Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study)

Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study

Adoptive immunotherapy for gastric cancer using zoledronate‑activated killer cells: A prospective observational study

Prognostic Nutritional Index as a Predictor of Postoperative Outcome in Patients Aged 85 Years or Older After Colorectal Cancer Surgery

Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer

Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety

Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer

Patient‐reported symptom burden as a prognostic factor in treatment with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial

A prospective Phase II study to examine the relationship between quality of life and adverse events of first‐line chemotherapy plus cetuximab in patients with KRAS wild‐type unresectable metastatic colorectal cancer: QUACK trial

S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102)

CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer

Effect of taurine on acinar cell apoptosis and pancreatic fibrosis in dibutyltin dichloride-induced chronic pancreatitis

Randomized, Phase II Study of Trastuzumab Beyond Progression in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: WJOG7112G (T-ACT Study)

Design of High-Density Cable Parameters for Controlling Spatial-Mode Dispersion of Randomly Coupled Multi-Core Fibers

Oral administration of taurine improves experimental pancreatic fibrosis

Prevalence and outcomes of acute hepatitis B in Okayama, Japan, 2006-2010

Histological study on pN upgrading of oral cancer

Neutrophil‑to‑lymphocyte ratio before each chemotherapy line predicts clinical outcomes in patients with unresectable gastric cancer

QoL analysis: A randomized phase 3 study of sequential versus combination treatment in first-line chemotherapy for metastatic colorectal cancer—The C-cubed study

Suchergebnisse filtern